These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 11675828)

  • 61. Combination therapy for acute myocardial infarction: will it survive?
    Kleiman NS
    J Am Coll Cardiol; 2003 Apr; 41(8):1261-3. PubMed ID: 12706918
    [No Abstract]   [Full Text] [Related]  

  • 62. [The future of fibrinolysis: from fibrinolytic treatment to reperfusion therapy].
    Théroux P
    Rev Esp Cardiol; 1992; 45 Suppl 2():84-90. PubMed ID: 1475513
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Aspirin augmentation of the efficacy of thrombolysis.
    O'Donnell CJ; Jonas MA; Hennekens CH
    Coron Artery Dis; 1995 Dec; 6(12):936-9. PubMed ID: 8723015
    [No Abstract]   [Full Text] [Related]  

  • 64. [Bolus fibrinolytic therapy in acute myocardial infarction].
    Pinelli G; Urbinati S
    Ital Heart J Suppl; 2001 Dec; 2(12):1360-2. PubMed ID: 11838360
    [No Abstract]   [Full Text] [Related]  

  • 65. [The prevention of reocclusion after thrombolysis in acute myocardial infarct: is tissue-type plasminogen activator really superior to streptokinase?].
    Negrini M
    G Ital Cardiol; 1995 Apr; 25(4):511-5. PubMed ID: 7677921
    [No Abstract]   [Full Text] [Related]  

  • 66. Aspirin after thrombolysis for MI.
    Seaton TL
    J Fam Pract; 1997 Mar; 44(3):249-50. PubMed ID: 9071241
    [No Abstract]   [Full Text] [Related]  

  • 67. Current state of thrombolytic therapy.
    Vorchheimer DA
    Curr Cardiol Rep; 1999 Sep; 1(3):212-20. PubMed ID: 10980844
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. GUSTO-III Investigators. Global Use of Strategies to Open Occluded Coronary Arteries.
    Gurbel PA; Serebruany VL; Shustov AR; Bahr RD; Carpo C; Ohman EM; Topol EJ
    J Am Coll Cardiol; 1998 Jun; 31(7):1466-73. PubMed ID: 9626821
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Experience with the thrombolytic therapy of myocardial infarct].
    Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA
    Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835
    [No Abstract]   [Full Text] [Related]  

  • 70. Dose-effect relationship estimation for thrombolytic therapy in acute myocardial infarction.
    Boissel JP; Leizorovicz A; Peyrieux JC
    Semin Thromb Hemost; 1987 Apr; 13(2):181-5. PubMed ID: 3114886
    [No Abstract]   [Full Text] [Related]  

  • 71. Therapy for early reperfusion after stroke.
    Juttler E; Kohrmann M; Schellinger PD
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):656-63. PubMed ID: 17122798
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Glycoprotein IIb/IIIa receptor inhibitors in acute ST-elevation myocardial infarction: will the combination with thrombolytics become reality?
    Zeymer U
    J Thromb Thrombolysis; 2003 Apr; 15(2):91-7. PubMed ID: 14618075
    [No Abstract]   [Full Text] [Related]  

  • 73. Thrombolysis in elderly patients with acute myocardial infarction.
    Berger AK
    Am J Geriatr Cardiol; 2003; 12(4):251-6; quiz 257. PubMed ID: 12888706
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Facilitated percutaneous intervention following combination therapy with reteplase and abciximab for acute myocardial infarction.
    Weinstock BS
    J Invasive Cardiol; 2002 Feb; 14(2):100-4; quiz 104-5. PubMed ID: 11818648
    [No Abstract]   [Full Text] [Related]  

  • 75. Rise and fall of glycoprotein IIb-IIIa inhibitors in ST-segment elevation myocardial infarction.
    Di Mario C
    Heart; 2014 Jun; 100(11):823-4. PubMed ID: 24659350
    [No Abstract]   [Full Text] [Related]  

  • 76. Acute myocardial infarction and thrombolytic therapy.
    Yasuda T; Gold HK
    Thromb Res Suppl; 1990; 10():73-9. PubMed ID: 2107600
    [No Abstract]   [Full Text] [Related]  

  • 77. Coupling drug and catheter therapy for myocardial infarction.
    Lincoff AM
    JAMA; 2004 Feb; 291(8):1000-2. PubMed ID: 14982917
    [No Abstract]   [Full Text] [Related]  

  • 78. Antithrombotics and antiplatelets in acute myocardial infarction.
    Wander GS; Gupta NK
    Indian Heart J; 2011; 63(1):58-65. PubMed ID: 23189866
    [No Abstract]   [Full Text] [Related]  

  • 79. Optimal treatment and current situation in reperfusion after thrombolysis for acute myocardial infarction.
    Dauterman K; Topol E
    Ann Med; 2002; 34(7-8):514-22. PubMed ID: 12553491
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Stenting versus thrombolysis in acute myocardial infarction trial (STAT).
    Indian Heart J; 2001; 53(3):375. PubMed ID: 11516047
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.